CHRS
Coherus Oncology, Inc.
Recent 8-K filings for CHRS
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:16 UTC earnings item 2.02item 9.01
Coherus Q1 LOQTORZI rev $11.8M (+61% YoY); net loss $36.9M; pipeline readouts mid-2026
source · CHRS on sec.gov